Therefore, increased levels of HTRA1 in the RPE of AMD patients with risk genotype might result in pathological choroidal neovascularization through (1) promoting degradation of Bruch’s membrane and compromising barrier function and (2) inhibiting BMP signaling thus removing a negative regulator for aberrant wound repair response. The gene discussed is HTRA1; the disease is age-related macular degeneration.